A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.

Source:http://linkedlifedata.com/resource/pubmed/id/9296217

Download in:

View as

Triples

General Info

PMID
9296217